Literature DB >> 29218995

Enantioselective Synthesis of Spliceostatin G and Evaluation of Bioactivity of Spliceostatin G and Its Methyl Ester.

Arun K Ghosh1, Guddeti Chandrashekar Reddy1, Andrew J MacRae2, Melissa S Jurica2.   

Abstract

An enantioselective total synthesis of spliceostatin G has been accomplished. The synthesis involved a Suzuki cross-coupling reaction as a key step. The functionalized tetrahydropyran ring was constructed from commercially available optically active tri-O-acetyl-d-glucal. Other key reactions include a highly stereoselective Claisen rearrangement, a Cu(I)-mediated 1,4 addition of MeLi to install the C8 methyl group, and a reductive amination to incorporate the C10 amine functionality of spliceostatin G. Biological evaluation of synthetic spliceostatin G and its methyl ester revealed that it does not inhibit splicing in vitro.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29218995      PMCID: PMC5972028          DOI: 10.1021/acs.orglett.7b03456

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  26 in total

1.  Synthesis of a C4-epi-C1-C6 fragment of FR901464 using a novel bromolactolization.

Authors:  Brian J Albert; Kazunori Koide
Journal:  Org Lett       Date:  2004-10-14       Impact factor: 6.005

Review 2.  The spliceosome: design principles of a dynamic RNP machine.

Authors:  Markus C Wahl; Cindy L Will; Reinhard Lührmann
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

3.  Total synthesis of FR901464, an antitumor agent that regulates the transcription of oncogenes and tumor suppressor genes.

Authors:  Brian J Albert; Ananthapadmanabhan Sivaramakrishnan; Tadaatsu Naka; Kazunori Koide
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

4.  Cytotoxic Spliceostatins from Burkholderia sp. and Their Semisynthetic Analogues.

Authors:  Haiyin He; Anokha S Ratnayake; Jeffrey E Janso; Min He; Hui Y Yang; Frank Loganzo; Boris Shor; Christopher J O'Donnell; Frank E Koehn
Journal:  J Nat Prod       Date:  2014-08-22       Impact factor: 4.050

5.  Total Synthesis of Thailanstatin A.

Authors:  K C Nicolaou; Derek Rhoades; Manjunath Lamani; Manas R Pattanayak; S Mothish Kumar
Journal:  J Am Chem Soc       Date:  2016-06-13       Impact factor: 15.419

6.  Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. II. Physico-chemical properties and structure elucidation.

Authors:  Takashi Sakai; Naoki Asai; Akifumi Okuda; Naoto Kawamura; Yoshiharu Mizui
Journal:  J Antibiot (Tokyo)       Date:  2004-03       Impact factor: 2.649

7.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

8.  Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.

Authors:  Kerstin A Effenberger; David D Anderson; Walter M Bray; Beth E Prichard; Nianchun Ma; Matthew S Adams; Arun K Ghosh; Melissa S Jurica
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

9.  High antitumor activity of pladienolide B and its derivative in gastric cancer.

Authors:  Momoko Sato; Naoki Muguruma; Tadahiko Nakagawa; Koichi Okamoto; Tetsuo Kimura; Shinji Kitamura; Hiromi Yano; Katsutaka Sannomiya; Takahiro Goji; Hiroshi Miyamoto; Toshiya Okahisa; Hiroaki Mikasa; Satoshi Wada; Masao Iwata; Tetsuji Takayama
Journal:  Cancer Sci       Date:  2013-12-04       Impact factor: 6.716

Review 10.  The spliceosome as target for anticancer treatment.

Authors:  R J van Alphen; E A C Wiemer; H Burger; F A L M Eskens
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

View more
  1 in total

Review 1.  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.

Authors:  Arun K Ghosh; Jennifer L Mishevich; Melissa S Jurica
Journal:  J Nat Prod       Date:  2021-05-11       Impact factor: 4.803

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.